Amendment of the Drugs and Cosmectics Rules relating to prohibition of testing of cosmetics on animals-regarding (NOTIFICATIONS)
Amendment of the Drugs and Cosmectics Rules relating to prohibition of testing of cosmetics on animals-regarding
Amendment of Rules relating to loan licensing system under the Drugs and Cosmetics Rules, 1945, for introduction of loan licensing system for drugs covered under CLAA scheme vide GSR 574(E) dated 17.07.2012-extracts of the rule amended (NOTIFICATIONS)
Amendment of Rules relating to loan licensing system under the Drugs and Cosmetics Rules, 1945, for introduction of loan licensing system for drugs covered under CLAA scheme vide GSR 574(E) dated 17.07.2012-extracts of the rule amended
Limiting of Acetaminophen (Paracetamol) in Prescription Combination Products ans giving Box Warning About its Liver Toxicity. (NOTIFICATIONS)
Limiting of Acetaminophen (Paracetamol) in Prescription Combination Products ans giving Box Warning About its Liver Toxicity.
KETAMINE HCL DRUG UNDER SCHEDULE X (NOTIFICATIONS)
KETAMINE HCL DRUG UNDER SCHEDULE X
KETAMINE HCL DRUG UNDER SCHEDULE X (NOTIFICATIONS) Read More »
Amendment of the Drugs and Cosmectics Rules relating to prohibition of testing of cosmetics on animals-regarding (NOTIFICATIONS)
Amendment of the Drugs and Cosmectics Rules relating to prohibition of testing of cosmetics on animals-regarding
Notification under Section 26A restricting the sale of Oxytocin drug (NOTIFICATIONS)
Notification under Section 26A restricting the sale of Oxytocin drug
Notification under Section 26A restricting the sale of Oxytocin drug (NOTIFICATIONS) Read More »
FDA OFFICE TO SHIFT TO BAMBOLIM (NOTIFICATIONS)
FDA OFFICE TO SHIFT TO BAMBOLIM
FDA OFFICE TO SHIFT TO BAMBOLIM (NOTIFICATIONS) Read More »
“Revocation of suspension of the Notification no. G.S.R. 378(E) dated 18/06/2013.” E) dated 18/06/2013.” (NOTIFICATIONS)
“Revocation of suspension of the Notification no. G.S.R. 378(E) dated 18/06/2013.” E) dated 18/06/2013.”
Prohibition of manufacture for sale, sale and distribution of Fixed dose combination of Flupenthixol and Melitracen for human use (NOTIFICATIONS)
Prohibition of manufacture for sale, sale and distribution of Fixed dose combination of Flupenthixol and Melitracen for human use
NOTIFICATION ON MEDICAL DEVICES (NOTIFICATIONS)
NOTIFICATION ON MEDICAL DEVICES
NOTIFICATION ON MEDICAL DEVICES (NOTIFICATIONS) Read More »